SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT06144710 · COMPLETED
Trial details
- NCT number
- NCT06144710
- Sponsor
- Hangzhou Sumgen Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2026-01-07
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.